Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

Filtered by:

Clear All

Speakers

Thomas Adams Trovagene Oncology CEO and Chairman Murray Aitken IQVIA Senior Vice President John Alam EIP Pharma President and CEO Al Altomari Agile Therapeutics, Inc. Chairman and CEO Katherine Andersen Silicon Valley Bank (SVB) Senior Market Manager Richard Andrews Azitra, Inc. President and CEO Armando Anido Zynerba Pharmaceuticals CEO William Annett OncoCyte CEO David Arthur Salarius Pharmaceuticals CEO David Atkins Congenica CEO David Baker Vallon Pharmaceuticals CEO Annette Bakker Children's Tumor Foundation President Jun Bao Impact Therapeutics President and CEO Jay A. Barth Amicus Therapeutics Chief Medical Officer Josep Bassaganya-Riera Landos Biopharma Chairman and CEO Heather Behanna Entasis Therapeutics Board Director Lewis H. Bender Intensity Therapeutics Founder and CEO Joseph Benkert Morrison & Foerster LLP Senior Advisor, National Security Harm-Jan Borgeld Merck KGaA Head Alliance Management Michael Bozik Knopp Biosciences Chief Executive Officer Aoife M. Brennan Synlogic President and Chief Executive Officer and Chief Medical Officer Isaac Bright RubrYc Therapeutics, Inc. CEO Josh Brodsky Alnylam Pharmaceuticals, Inc. Director, Investor Relations & Corporate Communications Noël Brown Cantor Fitzgerald Managing Director CARLOS BUESA-ARJOL ORYZON CEO Jason Butler JMP Securities Managing Director and Senior Analyst Philippe Calais CohBar, Inc. CEO Vered Caplan Orgenesis CEO and President James Caruso Cellectar Biosciences President and CEO John Celebi Sensei Biotherapeutics, Inc. President and CEO John Chambers H.C. Wainwright & Co., LLC President and Head of Investment Banking Phillip Chan CytoSorbents CEO Stephen Charles SATOR Therapeutics LLC Chief Executive Officer Yi Chen H.C. Wainwright & Co., LLC Managing Director of Equity Research George Chi CASI Pharmaceuticals, Inc. Chief Financial Officer Sabine Chlosta Triumvira Chief Medical Officer Matt Coffey Oncolytics Biotech Inc. President and CEO Grace Colón InCarda Therapeutics CEO and President Denis Corin Q BioMed Inc CEO Benjamin Cowen ImmunoMet Therapeutics CEO Roger Crystal Opiant Pharmaceuticals Chief Executive Officer Karim Dabbagh Second Genome President & CEO Steve Daly Adocia US General Manager Mark Day Bioasis Technologies Inc. Director, President & Chief Executive Officer Patrik De Haes OXURION NV CEO Carlos de Sousa Immunicum AB CEO Jie D'Elia Bristol-Myers Squibb Executive Director, Business Development Transactions Mark A. Demitrack Trevena SVP & CMO Jim Dentzer Curis, Inc President & CEO Anthony DiTonno Tenax Therapeutics, Inc. CEO Anil Diwan NanoViricides, Inc. President & Chairman Gere diZerega NanOlogy Chief Medical Officer Douglas Doerfler MaxCyte, Inc. President & CEO Vishal Doshi, B.Pharm, MSc AUM Biosciences Chairman & CEO Glyn Edwards Summit Therapeutics CEO Eric Falcand Servier Vice President, Head of Business Development and Licensing Jeff Farrah National Venture Capital Association (NVCA) General Counsel Craig Farrell AlphaSense VP of Business Development Brandon Folkes Cantor Fitzgerald Director Zandy Forbes MeiraGTx President & CEO Gregory Frank Biotechnology Innovation Organization Director, Infectious Disease Policy Stephen From EyeGate Pharmaceuticals, Inc. CEO and President Drew Fromkin Tarveda Therapeutics President, CEO and Chairman Steven Fruchtman Onconova Therapeutics, Inc. President & CEO Jeff Galvin American Gene Technologies CEO Chris Garabedian Xontogeny; Perceptive Advisors Chief Executive Officer;Portfolio Manager—Venture Michele GARUFI Nicox Chairman & CEO Evripidis Gavathiotis Albert Einstein College of Medicine;Selphagy Therapeutics, Inc. Associate Professor;Co-Founder, Director and Scientific Advisor Joseph Gerardi ImmunSYS, Inc. EVP, Chief Financial Officer David Giljohann Exicure CEO Andrew Gitkin Piper Jaffray Managing Director R. John Glasspool Massachusetts Institute of Technology Research Affiliate and Senior Advisor, FoCUS Center for Biomedical Innovation: NEWDIGS Lee Golden Espero BioPharma CMO Geoffrey Goodman Wells Fargo Securities Managing Director Robert Gould Fulcrum Therapeutics President & CEO James C. Greenwood Biotechnology Innovation Organization (BIO) President & CEO Annette Grimaldi BMO Capital Markets Managing Director Stefano Gulla Abcuro CEO Neeraj Gupta Genes2me LLP Founder & CEO Amanda Haidet-Phillips Muscular Dystrophy Association Scientific Portfolio Director Jim Healy Sofinnova General Partner Bill Hearl Immunomic Therapeutics, Inc. Founder and CEO Randy Hubbell Carmell Therapeutics President & CeO Keith D. Ignotz OcuMedic, Inc. President & CEO Jonathan Javitt, MD, MPH NeuroRx Chairman and CEO John H. Johnson Melinta Interim Chief Executive Officer and Director Sabrina Johnson Daré Bioscience, Inc. CEO Barry Kappel Sapience Therapeutics President and CEO Brian K. Kaspar AveXis Chief Scientific Officer Hans Keirstead AIVITA Biomedical, Inc. CEO Keith Kendall Aquestive Therapeutics CEO Ciara Kennedy Amplyx Pharmaceuticals, Inc. CEO Geert Kersten CEL-SCI Corporation Chief Executive Officer Sabrina Khan Aptorum Group Limited Chief Financial Officer Nadav Kidron Oramed Pharmaceuticals CEO Anthony Kim Marker Therapeutics, Inc. Chief Financial Officer Dan Kincaid Sense Diagnostics,Inc COO Paul Lammers Triumvira Immunologics President and Chief Executive Officer Chaim Lebovits Brainstorm Cell Therapeutics President &CEO Seth Lederman Tonix Pharmaceuticals CEO Thomas Lee Aptroum Group Limited CEO & CSO Roger Longman Real Endpoints Founder and Chairman Patrick(Yang) Lu Sirnaomics,Inc CEO Timothy Lu Senti Biosciences CEO & Co-Founder Doug Manion Kleo Pharmaceuticals CEO Jotin Marango ROTH Capital Partners Managing Director, Senior Research Analyst John Maslowski Fibrocell Science President & Chief Executive Officer David Mazzo Caladrius Biosciences, Inc. President and CEO Donald McCaffrey Resverlogix Corp. President & CEO Donald McCaffrey Zenith Epigenetics President & CEO Patrick McEnany Catalyst Pharma Chairman & CEO Tony Meehan VenatoRx Pharmaceuticals Chief Business Officer Vimal Mehta BioXcel Therapeutics CEO Geoff Meyerson Locust Walk Managing Partner and Co-founder Sara Michelmore MacDougall Senior Vice President, Investor Relations Michael Miller ProterixBio, Inc CEO Steven Miller Catalyst Pharmaceuticals, Inc. COO & CSO Christopher U. Missling Anavex Life Sciences Corp. President and CEO Tamer Mohamed Aspect Biosystems President & CEO Mark Moore LifeEDIT CEO Randall Moreadith Serina Therapeutics, Inc. CEO Piers Morgan Verona Pharma Chief Financial Officer Arikha Moses Concarlo Holdings, LLC CEO Brian Murphy Nemus Bioscience CEO James Nathanielsz Propanc Biopharma Inc. Chief Executive Officer Jeffrey Nau Oyster Point Pharma, Inc. President and CEO Kimberly Nearing Cedrus Group Managing Director, Head of Life Sciences Ron Newbold Otsuka America Pharmaceutical, Inc. Senior Vice President, US Business Development and Alliances William Newell Sutro Biopharma CEO Terrence Norchi Arch Therapeutics, Inc. President and Chief Executive Officer Dan O'Connor OncoSec President, Director & Chief Executive Officer Lynn O'Connor Vos Muscular Dystrophy Association (MDA) President and CEO Pete OHeeron SpinalCyte, LLC CEO Frederic Ors IMV Inc. CEO Kevin Outterson Boston University;CARB-X Professor and N. Neal Pike Scholar in Health and Disability Law;Executive Director & Principal Investigator Jerry Parrott BioMarker Strategies, LLC President, CEO and Director Daniel Passeri Cue Biopharma President & CEO Snehal Patel Greenwich LifeSciences CEO Stuart Paul Rockwell Medical, Inc President & CEO Joseph Payne Arcturus Therapeutics CEO Andrew Pearlman Galimedix Therapeutics CEO Christopher Peetz Mirum Pharmaceuticals, Inc. President Kah-Whye Peng Vyriad CTO Eleanor Perfetto National Health Council Senior Vice President, Strategic Initiatives Adelene Perkins Infinity Pharamaceuticals CEO Manos Perros Entasis Therapeutics President & Chief Executive Officer Susan Peschin Alliance for Aging Research President and CEO Richard Pestell CytoDyn Ron Philip Spark Therapeutics Chief Commercial Officer Peter Pitts Center for Medicine in the Public Interest President Nader Pourhassan CytoDyn Inc. CEO & President Adityo Prakash Verseon CEO Christopher Prior Innovate Biopharmaceuticals, Inc CEO Dennis J. Purcell Aisling Capital LLC Founder and Senior Advisor Yasmeen Rahimi ROTH Capital Partners Managing Director and Senior Research Analyst Lydia Ramsey Business Insider Senior Reporter Spiro Rombotis Cyclacel Pharmaceuticals, Inc. President and Chief Executive Officer Philip Ross J.P. Morgan Vice Chairman William Rust SERAXIS INC. Chief Executive Officer Charles S. Ryan Neurotrope CEO Lisa Schaefer Biotechnology Innovation Organization (BIO) Director of Financial Services and Tax Policy Stefanie Schubert SRH University Heidelberg Professor of Economics Amy Schulman Lyndra Inc CEO Duane Schulthess Vital Transformation Managing Director Dara Schuster T1D Exchange Chief Executive Officer Phillip Schwartz Entera Bio CEO Sandesh Seth Actinium Pharmaceuticals, Inc. Chairman and CEO Steven Shallcross syntheticbiologics.com Chief Executive Officer & Chief Financial Officer Akshaya Shanmugam Lumme Inc CEO Jennifer Sheng Citi Managing Director, Equity Capital Markets Sanjay Shukla aTyr Pharma, Inc. President and CEO Shawn Singh VistaGen Therapeutics, Inc. Chief Executive Officer William Slattery Deerfield Partner Yochi Slonim Anima Biotech Inc. Co-founder and CEO Julie Anne Smith E-Scape Bio President & CEO Wolfgang Söhngen PAION AG CEO Sapna Srivastava Angelos Stergiou SELLAS Life Sciences Group President & CEO Colin Story OxSonics Limited CEO Jack Stover Interpace Diagnostics President & CEO Clark Sullivan Cox Biosciences LLC President Le Sun AbMax Biotechnology CO., LTD President & CEO Salim Syed Mizuho Head of Biotechnology Research, Senior Biotechnology Analyst, Managing Director Marco Taglietti Scynexis President and Chief Executive Officer Mark Tang Good Health Capital, New York Managing Director Andrew Tasker Femeda Ltd CEO James Taylor Precision NanoSystems CEO RJ Tesi INmune Bio CEO David Thomas Biotechnology Innovation Organization (BIO) Vice President, Industry Research Nancy Thornberry Kallyope Chief Executive Officer Michael Tymianski NoNO Inc. CEO Nassim Usman Catalyst Biosciences President & CEO Dan Vickery Urigen Pharmaceuticals, Inc. CEO Daniel Vitt Immunic AG CEO Robert Ward Eloxx Pharmaceuticals Chairman and CEO Stefan Weber Newron Pharmaceuticals SpA CEO Yaron Werber Cowen Managing Director Erica Whittaker UCB Ventures Vice President & Head Brian Windsor Lung Therapeutics CEO Jeffrey Wolf Heat Biologics, Inc. CEO Jinzi J. Wu Ascletis Pharma Inc. Founder, Chairman, and CEO Chris Xu Cesca Therapeutics Inc. CEO Nader Yaghoubi PathMaker Neurosystems Inc. President and Chief Executive Officer Peter Young Pappas Capital Executive-In-Residence